Skip to main content

Meeker David P

In the past year, 1 open-market sale filing worth $5.13M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$5.13M
1 filing
Net
−$5.13M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Meeker David P as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

RYTM Rhythm Pharmaceuticals, Inc.

President and CEO6 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 14, 2026 (view filing)7:37 PM ETSep 14Same dayMeeker David PPresident and CEOSSale−50.0K$102.67−$5.13M−17.3%239.3K after5 lots10b5-1
Jun 5, 2025 (view filing)Jun 32 daysMeeker David PPresident and CEOSSale−43.6K$65.04−$2.84M−17.8%201.8K after2 lots10b5-1
Feb 19, 2025 (view filing)Feb 19Same dayMeeker David PPresident and CEOSSale−9.90K$57.22−$566.2K−4.7%201.3K after10b5-1
Feb 4, 2025 (view filing)Feb 4Same dayMeeker David PPresident and CEOSSale−4.28K$59.43−$254.2K−2.2%189.9K after
Mar 19, 2024 (view filing)Mar 19Same dayMeeker David PPresident and CEOSSale−45.5K$39.22−$1.78M−20.7%174.6K after
Feb 5, 2024 (view filing)Feb 14 daysMeeker David PPresident and CEOSSale−4.36K$45.06−$196.5K−3.5%121.1K after

TRVI Trevi Therapeutics, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 29, 2024 (view filing)Aug 272 daysMeeker David PDirectorSSale−4.55K$2.93−$13.3K−1.3%352.5K after